Immunocore Holdings plc's revenue has grown 32% a year over three years. Revenue growth, 3-year annual rate: +32% (Biotechnology median +21%). Years of annual history on file: 5, FY2021 to FY2025, as filed.

IMCRImmunocore Holdings plc

Healthcare

$31.03-7.5% 1Y

$31.03

$27.7952 weeks$40.22

Latest close: below its 200-day averageOct 23, 2026what changed →

Is it growing?

Good

Growing: revenue growing +21% year on year and operating margin widening (+7.8 points).

2 good, 1 without data

Revenue trend+21% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction+7.8 points operating

Trailing-twelve-month operating margin, -5.4% now against -13.2% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.